 |
Chimeric, humanized monoclonal antibody to staphylococcus |
|---|---|
| Trade Name | |
| Orphan Indication | Prophylaxis of Staphylococcus epidermidis sepsis in low birth weight (1500 grams or less) infants |
| USA Market Approval | USA |
| USA Designation Date | 2000-08-03 00:00:00 |
| Sponsor | Biosynexus, Inc.;9298 Gaither Road;Rockville, Maryland, 20877 |
